Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$407M |
| 2 |
ExxonMobil
XOM
|
+$212M |
| 3 |
Microsoft
MSFT
|
+$200M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$183M |
| 5 |
Johnson & Johnson
JNJ
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$58.6M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$43M |
| 3 |
BCE
BCE
|
+$39M |
| 4 |
PETM
PETSMART INC
PETM
|
+$11.8M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.69% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 10.89% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Consumer Staples | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Deere & Co
DE
$164B
| $45.5M | 0.12% |
518,719
+202,200
| +64% | +$17.9M |
|
202
Allstate
ALL
$68.2B
| $45.5M | 0.12% |
638,973
+236,800
| +59% | +$16.7M |
|
|
203
BCE
BCE
$21B
| $45.4M | 0.12% |
1,076,840
-875,800
| -45% | -$39M |
|
204
Healthpeak Properties
DOC
$14.4B
| $45.1M | 0.12% |
1,146,981
+263,081
| +30% | +$10.6M |
|
205
Imperial Oil
IMO
$62.3B
| $44.8M | 0.12% |
1,126,500
+213,400
| +23% | +$8.31M |
|
206
Fidelity National Information Services
FIS
$21.9B
| $44.5M | 0.12% |
653,313
+172,000
| +36% | +$11.2M |
|
|
PARA
207
DELISTED
Paramount Global Class B
PARA
| $44.4M | 0.12% |
731,825
+279,500
| +62% | +$16.3M |
|
208
Corning
GLW
$136B
| $44.3M | 0.12% |
1,953,812
+751,100
| +62% | +$17.9M |
|
209
Exelon
EXC
$45.8B
| $44M | 0.12% |
1,835,681
+718,666
| +64% | +$17.8M |
|
210
Aflac
AFL
$61.2B
| $43.9M | 0.12% |
1,372,590
+530,200
| +63% | +$16.2M |
|
211
Sherwin-Williams
SHW
$88.1B
| $43.8M | 0.12% |
461,883
+129,900
| +39% | +$12.1M |
|
212
Marathon Petroleum
MPC
$90B
| $43.7M | 0.12% |
853,696
+326,800
| +62% | +$15.7M |
|
213
VF Corp
VFC
$5.86B
| $43.4M | 0.12% |
612,608
+214,524
| +54% | +$14.9M |
|
214
Applied Materials
AMAT
$415B
| $43.4M | 0.12% |
1,921,922
+792,100
| +70% | +$19M |
|
215
Vertex Pharmaceuticals
VRTX
$133B
| $43.2M | 0.12% |
366,409
+145,100
| +66% | +$17.4M |
|
216
Chipotle Mexican Grill
CMG
$40.7B
| $42.7M | 0.11% |
3,279,350
+835,000
| +34% | +$11.4M |
|
217
J.M. Smucker
SJM
$12.6B
| $42.4M | 0.11% |
366,399
+39,000
| +12% | +$4.27M |
|
218
Perrigo
PRGO
$1.75B
| $42.1M | 0.11% |
254,362
+98,400
| +63% | +$15.7M |
|
219
American Electric Power
AEP
$66.9B
| $41.9M | 0.11% |
745,289
+292,200
| +64% | +$17.3M |
|
|
BHI
220
DELISTED
Baker Hughes
BHI
| $41.9M | 0.11% |
659,128
+254,700
| +63% | +$15.4M |
|
221
Sysco
SYY
$40.1B
| $41.8M | 0.11% |
1,107,240
+329,500
| +42% | +$13M |
|
222
Humana
HUM
$46.3B
| $41.6M | 0.11% |
233,626
+90,400
| +63% | +$14.3M |
|
|
LNKD
223
DELISTED
LinkedIn Corporation
LNKD
| $41.2M | 0.11% |
165,000
+65,700
| +66% | +$16.3M |
|
224
Illumina
ILMN
$29B
| $40.1M | 0.11% |
222,300
+89,025
| +67% | +$16.8M |
|
225
Pembina Pipeline
PBA
$27.8B
| $40.1M | 0.11% |
1,275,900
+269,800
| +27% | +$8.68M |
|
Similar funds
Swiss National Bank's Q1 2015 Portfolio in Review
As of Q1 2015, Swiss National Bank held 2,582 positions worth $37.5B, up 40% from $26.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Swiss National Bank deployed $10.3B of net new capital in Q1 2015, opening 14 new positions and adding to 1,633 existing holdings. Its largest new stake was Infosys: 2,143,352 shares worth $18.8M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was BCE, an estimated $39M trimmed.
- Swiss National Bank's largest Q1 2015 buy was Infosys: 2,143,352 shares worth $18.8M.
- Swiss National Bank added most to Apple in Q1 2015, an estimated $407M increase.
- Swiss National Bank's biggest Q1 2015 reduction was BCE, cutting an estimated $39M.
- Swiss National Bank fully exited Allergan Inc in Q1 2015, selling an estimated $58.6M.
- Swiss National Bank's ten largest holdings make up 14% of its $37.5B portfolio in Q1 2015.
- Swiss National Bank opened 14 new positions and closed 36 in Q1 2015.
- Swiss National Bank's portfolio value rose 40% quarter-over-quarter to $37.5B.
Based on Swiss National Bank's 13F filing for Q1 2015, filed 6 May 2015.